Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

ACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020


ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2020, at 10:00 a.m. Pacific Time, followed by a question and answer breakout session.

A live webcast of ACADIA's presentation and breakout session will be accessible on the company's website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through February 14, 2020.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. ACADIA has developed and commercialized the first and only medicine approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA also has ongoing clinical development efforts in additional areas with significant unmet need, including dementia-related psychosis, major depressive disorder, the negative symptoms of schizophrenia, and Rett syndrome. This press release and further information about ACADIA can be found at: www.acadia-pharm.com.


These press releases may also interest you

at 09:05
Contentful, a leading composable content platform for digital-first businesses, today announced the general availability of Contentful Studio, its newest product. Contentful Studio empowers digital teams, including marketers and designers, to...

at 09:05
Pelago, the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced $58 million in new funding on the strength of customer growth and validated ROI, bringing total funding to $151 million....

at 09:05
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that a podium talk and multiple abstracts featuring data for the company's NeXT Personal® whole genome-based, tumor-informed assay for ultra-sensitive ctDNA...

at 09:05
Brightly, a Siemens company and the global leader in intelligent asset management solutions, today announced the appointments of Christine Engle, senior vice president of people and operations, and Nigel Hughes, head of product, to its leadership...

at 09:05
AppViewX, the leader in automated machine identity management (MIM) and application security, and Fortanix, a leader in data-first security and pioneer of Confidential Computing, today announced a partnership to offer cloud-delivered secure digital...

at 09:05
StartupOS, a leader in StartupTech, today unveiled Bolt Startup AI, the industry's first generative AI-powered chatbot that helps founders use natural language to build, enhance, and scale their startup. The new tool also enables enterprise, private...



News published on and distributed by: